These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35898652)

  • 41. Early Adolescence Prefrontal Cortex Alterations in Female Rats Lacking Dopamine Transporter.
    Illiano P; Leo D; Gainetdinov RR; Pardo M
    Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33562738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-terminal tagging of the dopamine transporter impairs protein expression and trafficking in vivo.
    Vecchio LM; Bermejo MK; Beerepoot P; Ramsey AJ; Salahpour A
    Mol Cell Neurosci; 2014 Jul; 61():123-32. PubMed ID: 24886986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Social isolation in rats: Effects on animal welfare and molecular markers for neuroplasticity.
    Begni V; Sanson A; Pfeiffer N; Brandwein C; Inta D; Talbot SR; Riva MA; Gass P; Mallien AS
    PLoS One; 2020; 15(10):e0240439. PubMed ID: 33108362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice.
    Powell SB; Lehmann-Masten VD; Paulus MP; Gainetdinov RR; Caron MG; Geyer MA
    Psychopharmacology (Berl); 2004 May; 173(3-4):310-7. PubMed ID: 14747902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Influence of the
    Shumakova AA; Apryatin SA; Shipelin VA; Efimova EV; Fesenko ZS; Gmoshinski IV
    Vopr Pitan; 2020; 89(5):17-27. PubMed ID: 33211914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.
    Salvatore MF; Calipari ES; Jones SR
    ACS Chem Neurosci; 2016 Jul; 7(7):941-51. PubMed ID: 27124386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
    Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
    Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder.
    Mereu M; Contarini G; Buonaguro EF; Latte G; Managò F; Iasevoli F; de Bartolomeis A; Papaleo F
    Neuropharmacology; 2017 Jul; 121():179-194. PubMed ID: 28454982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rats Lacking Dopamine Transporter Display Increased Vulnerability and Aberrant Autonomic Response to Acute Stress.
    Illiano P; Bigford GE; Gainetdinov RR; Pardo M
    Biomolecules; 2020 May; 10(6):. PubMed ID: 32486390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant responses in social interaction of dopamine transporter knockout mice.
    Rodriguiz RM; Chu R; Caron MG; Wetsel WC
    Behav Brain Res; 2004 Jan; 148(1-2):185-98. PubMed ID: 14684259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine.
    Budygin EA; Brodie MS; Sotnikova TD; Mateo Y; John CE; Cyr M; Gainetdinov RR; Jones SR
    Proc Natl Acad Sci U S A; 2004 May; 101(20):7781-6. PubMed ID: 15136721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No effect of sex on ethanol intake and preference after dopamine transporter (DAT) knockdown in adult mice.
    Bahi A; Dreyer JL
    Psychopharmacology (Berl); 2019 Apr; 236(4):1349-1365. PubMed ID: 30539268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.
    Carboni E; Spielewoy C; Vacca C; Nosten-Bertrand M; Giros B; Di Chiara G
    J Neurosci; 2001 May; 21(9):RC141: 1-4. PubMed ID: 11312315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
    Del'Guidice T; Lemasson M; Etiévant A; Manta S; Magno LA; Escoffier G; Roman FS; Beaulieu JM
    Psychopharmacology (Berl); 2014 Jan; 231(1):109-22. PubMed ID: 23912772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intranasal Dopamine Reduces In Vivo [(123)I]FP-CIT Binding to Striatal Dopamine Transporter: Correlation with Behavioral Changes and Evidence for Pavlovian Conditioned Dopamine Response.
    de Souza Silva MA; Mattern C; Decheva C; Huston JP; Sadile AG; Beu M; Müller HW; Nikolaus S
    Front Behav Neurosci; 2016; 10():80. PubMed ID: 27148001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altering the development of the dopaminergic system through social play in rats: Implications for anxiety, depression, hyperactivity, and compulsivity.
    Parvopassu A; Oggiano M; Festucci F; Curcio G; Alleva E; Adriani W
    Neurosci Lett; 2021 Aug; 760():136090. PubMed ID: 34197903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Analysis of dopamine transporter knockout mice as an animal model of AD/HD].
    Kasahara Y; Kubo Y; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):185-9. PubMed ID: 25069256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D
    Gowrishankar R; Gresch PJ; Davis GL; Katamish RM; Riele JR; Stewart AM; Vaughan RA; Hahn MK; Blakely RD
    J Neurosci; 2018 Jun; 38(23):5302-5312. PubMed ID: 29739866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice.
    Mead AN; Rocha BA; Donovan DM; Katz JL
    Eur J Neurosci; 2002 Aug; 16(3):514-20. PubMed ID: 12193195
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of Cdk5 activity is involved on Dopamine Transporter expression and function: Evidences from an animal model of Attention-Deficit Hyperactivity Disorder.
    Fernández G; Krapacher F; Ferreras S; Quassollo G; Mari MM; Pisano MV; Montemerlo A; Rubianes MD; Bregonzio C; Arias C; Paglini MG
    Exp Neurol; 2021 Dec; 346():113866. PubMed ID: 34537209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.